In a recent letter to the FDA, Sidney Wolfe of Public Citizen, a Washington, D.C.-based citizens' advocacy group, and David Juurlink, a researcher at Sunnybrook Health Sciences Centre in Toronto whose recent study found Avandia-associated health risks, called the TIDE trial "unethical" and urged the FDA to halt the study. They insist that Avandia offers no advantage over Actos, yet comes with significantly greater health risks.
Friday, July 16, 2010
Observations: Diabetes drug investigation yields unclear decision from FDA committee
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment